51 results on '"Polypoidal choroidal vasculopathy"'
Search Results
2. Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment
3. Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)
4. A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
5. ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
6. OCT in Rare Chorioretinal Diseases
7. Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
8. Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy
9. Clinical Implication of Aflibercept in PCV Treatment in China
10. Conbercept for Polypoidal Choroidal Vasculopathy(START Study)
11. An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
12. OCTA and Polypoidal Choroidal Vasculopathy
13. Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept
14. Aflibercept in Polypoidal Choroidal Vasculopathy (PLANET)
15. Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)
16. Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy
17. Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy (ATLANTIC)
18. Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy (CyPov)
19. Biomarkers of Common Eye Diseases
20. Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy
21. Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid
22. Initial Versus Delayed PDT Combination With Conbercept in PCV
23. Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT) (EVEREST II)
24. Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy
25. Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy (RANTA)
26. Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
27. Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen
28. Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment (PCV)
29. Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2) (PEARL2)
30. The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) (STAR)
31. Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
32. Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation (EPIC)
33. Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy
34. Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers
35. Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy (VAULT)
36. Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy
37. Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) (PEARL)
38. Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) (RIVAL)
39. iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) (PED)
40. IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD
41. Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (FVF4140S)
42. Vascular Endothelial Growth Factor (VEGF) & LOC387715/HTRA1 Polymorphism in Polypoidal Choroidal Vasculopathy
43. Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)
44. LOC387715/HTRA1 and the Combined Photodynamic Therapy With Intravitreal Bevacizumab in Polypoidal Choroidal Vasculopathy
45. LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy in a Korean Population (PCV)
46. Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy
47. Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)
48. Response to Ranibizumab in Polypoidal Choroidal Vasculopathy (PCV)and SNPs
49. Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy (PEARL2)
50. Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.